ATH.AX · ALTERITY THERAPEUTICS LIMITED
Australia · RS rating 13 · As of 2026-10-14
| Price | 0.32 AUD |
|---|---|
| 1-day change | -4.4% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 10 / 5 / 29 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 20 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +54.2% |
| Market cap (USD) | $54.0M |